Bruker Corporation (BRKR)
NASDAQ: BRKR · IEX Real-Time Price · USD
61.64
-0.69 (-1.11%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Bruker Revenue
Bruker had revenue of $3.00B in the twelve months ending March 31, 2024, with 14.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $721.70M with 5.31% year-over-year growth. In the year 2023, Bruker had annual revenue of $2.96B with 17.14% growth.
Revenue (ttm)
$3.00B
Revenue Growth
+14.49%
P/S Ratio
3.11
Revenue / Employee
$309,148
Employees
9,707
Market Cap
9.33B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.96B | 433.80M | 17.14% |
Dec 31, 2022 | 2.53B | 112.80M | 4.67% |
Dec 31, 2021 | 2.42B | 430.40M | 21.66% |
Dec 31, 2020 | 1.99B | -85.10M | -4.11% |
Dec 31, 2019 | 2.07B | 177.00M | 9.34% |
Dec 31, 2018 | 1.90B | 129.70M | 7.34% |
Dec 31, 2017 | 1.77B | 154.60M | 9.59% |
Dec 31, 2016 | 1.61B | -12.50M | -0.77% |
Dec 31, 2015 | 1.62B | -185.10M | -10.23% |
Dec 31, 2014 | 1.81B | -30.50M | -1.66% |
Dec 31, 2013 | 1.84B | 48.00M | 2.68% |
Dec 31, 2012 | 1.79B | 139.70M | 8.46% |
Dec 31, 2011 | 1.65B | 346.80M | 26.58% |
Dec 31, 2010 | 1.30B | 190.40M | 17.08% |
Dec 31, 2009 | 1.11B | 7.40M | 0.67% |
Dec 31, 2008 | 1.11B | 74.70M | 7.24% |
Dec 31, 2007 | 1.03B | 181.00M | 21.26% |
Dec 31, 2006 | 851.40M | 479.15M | 128.72% |
Dec 31, 2005 | 372.25M | 15.26M | 4.28% |
Dec 31, 2004 | 356.99M | 96.31M | 36.95% |
Dec 31, 2003 | 260.68M | 40.02M | 18.14% |
Dec 31, 2002 | 220.66M | 45.38M | 25.89% |
Dec 31, 2001 | 175.28M | 98.68M | 128.82% |
Dec 31, 2000 | 76.60M | 11.91M | 18.41% |
Dec 31, 1999 | 64.69M | 22.48M | 53.27% |
Dec 31, 1998 | 42.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walgreens Boots Alliance | 145.53B |
Smith & Nephew | 5.55B |
Encompass Health | 4.96B |
Catalent | 4.14B |
Charles River Laboratories International | 4.11B |
AptarGroup | 3.54B |
Teleflex | 3.00B |
Qiagen | 1.94B |
BRKR News
- 18 hours ago - Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin - Business Wire
- 7 days ago - Cellens Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection - Business Wire
- 4 weeks ago - Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics - Business Wire
- 4 weeks ago - Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications - Business Wire
- 4 weeks ago - Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories - Business Wire
- 4 weeks ago - Bruker Corporation to Present at Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Bruker Announces Pricing of Public Offering of Common Stock - Business Wire
- 4 weeks ago - Bruker Announces Public Offering of Common Stock - Business Wire